Sector valuations Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2024-09-11 EDT 5-day change 1st Jan Change
31.08 USD -7.20% Intraday chart for Supernus Pharmaceuticals, Inc. -11.20% +7.39%
Main competitors
Add to a list
P/E ratio Price to Book PEG EV / Sales EV / EBITDA EV / EBIT Yield (Y) Capi. ($)
107.17x - 0.08x - - - - 1.71B
24.7x 2.558 4.16x3.77x13.33x20.66x+1.36%81.29B
24.95x 2.000 -1.73x2.8x11.87x15.14x+1.81%12.01B
60.04x 4.332 5.83x4.34x51.17x80.87x+0.35%6.75B
109.64x 21.68 -0.35x14.55x79.58x96.05x-.--%5.83B
34.62x 2.924 0.87x6.21x19.28x38.29x+0.65%2.36B
11.38x 1.058 0.17x - - - +17.58%1.93B
29.66x 6.220 0.34x - - - - 1.87B
17.45x 2.106 1.92x - - - +0.74%1.34B
9.64x -8.061000 0x1.02x3.59x3.95x-.--%1.23B
12.74x 0.6883 1.32x - - - +2.61%1.08B
59.37x 33.16 -0.42x5.73x78.92x-906.67x-.--%1.08B
29.77x 1.081 0.59x1.83x16.19x23.85x - 935M
-41.44x 4.287 0.15x - - - - 926M
Average 34.98x 5.7 0.92x 5.03x 34.24x -78.48x +2.51% 8.6B
Weighted average by Cap. 31.56x 3.73 3.01x 4.29x 19.61x 18.89x +1.51%
Specialty & Advanced Pharmaceuticals
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW